Hanmei Li Selected Research

Hanmei Li Research Topics

Disease

19	Neoplasms (Cancer) 04/2024 - 01/2016
5	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2016
5	Inflammation (Inflammations) 02/2024 - 01/2017
4	Melanoma (Melanoma, Malignant) 04/2024 - 01/2017
2	Neoplasm Metastasis (Metastasis) 04/2024 - 02/2024
2	Glioma (Gliomas) 02/2024 - 02/2018
2	Wounds and Injuries (Trauma) 07/2023 - 01/2020
2	Postoperative Pain 01/2022 - 01/2017
2	Experimental Arthritis 01/2017 - 01/2017
1	Bites and Stings (Sting) 04/2024
1	Ulcerative Colitis 02/2024
1	Brain Diseases (Brain Disorder) 01/2024
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2024
1	Burns 07/2023
1	Nasopharyngeal Carcinoma 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2023
1	Macular Degeneration (Age-Related Maculopathy) 01/2023
1	Pericardial Effusion 02/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Osteoarthritis 06/2021
1	Congenital Heart Defects (Congenital Heart Defect) 08/2020
1	Vascular Ring 08/2020

Drug/Important Bio-Agent (IBA)

5	MicellesIBA 02/2017 - 01/2016
4	AntigensIBA 04/2024 - 01/2017
4	Peptides (Polypeptides)IBA 02/2024 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 03/2018
3	Liposomes (Liposome)IBA 01/2023 - 12/2021
2	InterferonsIBA 04/2024 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 02/2017
2	poly(lactide) (polylactic acid)IBA 02/2024 - 08/2020
2	Protein CoronaIBA 02/2024 - 01/2023
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2024 - 01/2023
2	CyclodextrinsIBA 02/2024 - 10/2017
2	AlbuminsIBA 01/2023 - 12/2021
2	maleimideIBA 07/2022 - 12/2021
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2018 - 03/2018
1	IonsIBA 04/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2024
1	NucleosidesIBA 04/2024
1	MetalsIBA 04/2024
1	ManganeseIBA 04/2024
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	Polysaccharides (Glycans)IBA 04/2024
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2024
1	Scavenger Receptors (Scavenger Receptor)IBA 02/2024
1	Phosphatidylcholines (Phosphatidylcholine)IBA 02/2024
1	LipidsIBA 02/2024
1	didodecyldimethylammoniumIBA 02/2024
1	Hyaluronic Acid (Hyaluronan)IBA 02/2024
1	magnololIBA 02/2024
1	Photosensitizing Agents (Photosensitizers)IBA 02/2024
1	Amantadine (Aman)FDA LinkGeneric 02/2024
1	DisulfidesIBA 02/2024
1	Immunologic Factors (Immunomodulators)IBA 02/2024
1	phytochlorinIBA 02/2024
1	demethylcantharidinIBA 02/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	CytokinesIBA 09/2023
1	Antiviral Agents (Antivirals)IBA 07/2023
1	EmulsionsIBA 07/2023
1	Lipid NanoparticlesIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	aspartylglycineIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2023
1	QuercetinIBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	Sulfhydryl Compounds (Thiols)IBA 07/2022
1	DiureticsIBA 02/2022
1	EstersIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	SaltsIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Thymidine Monophosphate (TMP)IBA 06/2021
1	tetramethylpyrazineIBA 06/2021
1	isothiocyanic acidIBA 01/2021
1	sulforaphaneIBA 01/2021
1	SuspensionsIBA 08/2020
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2020
1	Tissue Adhesives (Tissue Adhesive)IBA 01/2020

Therapy/Procedure

10	Therapeutics 04/2024 - 01/2017
3	Aftercare (After-Treatment) 02/2022 - 03/2018
2	Photochemotherapy (Photodynamic Therapy) 02/2024 - 01/2023
2	Intravenous Injections 12/2021 - 01/2017
2	Immunotherapy 10/2017 - 01/2017
1	Injections 02/2024
1	Immunomodulation 02/2024
1	Intranasal Administration 01/2024
1	Intravitreal Injections 01/2023
1	Radiotherapy 01/2023
1	Local Anesthesia 01/2022
1	Intra-Articular Injections 06/2021